Symposia: CAR-T Cell Therapies: Basic and Translational
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Combination therapy, Apoptosis, Translational Research, CLL, Lymphomas, Non-Hodgkin lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Genomics, T Cell lymphoma, Diseases, Immune mechanism, Indolent lymphoma, Treatment Considerations, Biological therapies, Immunology, Aggressive lymphoma, Lymphoid Malignancies, Adverse Events, Biological Processes, Technology and Procedures, Omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Combination therapy, Apoptosis, Translational Research, CLL, Lymphomas, Non-Hodgkin lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Genomics, T Cell lymphoma, Diseases, Immune mechanism, Indolent lymphoma, Treatment Considerations, Biological therapies, Immunology, Aggressive lymphoma, Lymphoid Malignancies, Adverse Events, Biological Processes, Technology and Procedures, Omics technologies
Monday, December 9, 2024: 2:45 PM-4:15 PM
Room 6CF
(San Diego Convention Center)
Moderators:
Karlo Perica, MD, PhD,
and
Maksim Mamonkin, PhD, Center For Cell and Gene Therapy
Disclosures:
Mamonkin: March Bio: Consultancy, Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees, Other: Leadership, Patents & Royalties: Licensing, Research Funding; NKILT Therapeutics: Membership on an entity's Board of Directors or advisory committees; Fate Therapeutics: Honoraria, Other: Travel, Patents & Royalties: Licensing, Research Funding; Allogene Therapeutics: Patents & Royalties: Licensing; Beam Therapeutics: Patents & Royalties; Amgen: Consultancy, Honoraria, Other: Travel; Galapagos NV: Consultancy, Honoraria, Other: Travel; Laverock Therapeutics: Consultancy.
The majority of the abstracts in this session will highlight acute and late toxicities that may occur after CAR T cell therapy.
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH